CABA vs EXPD · $143.9M cap vs P/E 26, rev $10.60B
Cabaletta Bio Inc (CABA) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
CABA does not have a complete income-statement cache yet.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
CABA currently screens at market cap $143.9M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the CABA and EXPD stock pages for the full models.
Not investment advice.